These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 35777588)

  • 21. Effects of Wine Components in Inflammatory Bowel Diseases.
    Vrdoljak J; Kumric M; Ticinovic Kurir T; Males I; Martinovic D; Vilovic M; Bozic J
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.
    Piechota-Polanczyk A; Fichna J
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):605-20. PubMed ID: 24798211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of natural products actions on cytokines in inflammatory bowel disease.
    Hur SJ; Kang SH; Jung HS; Kim SC; Jeon HS; Kim IH; Lee JD
    Nutr Res; 2012 Nov; 32(11):801-16. PubMed ID: 23176791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair.
    Lei F; Zeng F; Yu X; Deng Y; Zhang Z; Xu M; Ding N; Tian J; Li C
    J Nanobiotechnology; 2023 Aug; 21(1):275. PubMed ID: 37596598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease.
    Aardoom MA; Veereman G; de Ridder L
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New molecules in the treatment of inflammatory bowel disease].
    Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2016; 39(6):411-23. PubMed ID: 26631943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Insight into Herbal Bioactives-based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy.
    Harwansh RK; Chauhan S; Deshmukh R; Mazumder R
    Curr Pharm Biotechnol; 2024; 25(14):1835-1857. PubMed ID: 38310453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic implications of functional tea ingredients for ameliorating inflammatory bowel disease: a focused review.
    Huang Y; Xing K; Qiu L; Wu Q; Wei H
    Crit Rev Food Sci Nutr; 2022; 62(19):5307-5321. PubMed ID: 33635174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
    Tambuwala MM
    Inflamm Bowel Dis; 2016 Mar; 22(3):719-23. PubMed ID: 26717321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
    Peter I; Dubinsky M; Bressman S; Park A; Lu C; Chen N; Wang A
    JAMA Neurol; 2018 Aug; 75(8):939-946. PubMed ID: 29710331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changing paradigm in the management of inflammatory bowel disease].
    Jang BI
    Korean J Gastroenterol; 2015 May; 65(5):268-72. PubMed ID: 25998972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?
    Vaghari-Tabari M; Alemi F; Zokaei M; Moein S; Qujeq D; Yousefi B; Farzami P; Hosseininasab SS
    Crit Rev Food Sci Nutr; 2024; 64(13):4155-4178. PubMed ID: 36345891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol attenuates intestinal injury in irradiated rats via PI3K/Akt/mTOR signaling pathway.
    Radwan RR; Karam HM
    Environ Toxicol; 2020 Feb; 35(2):223-230. PubMed ID: 31633274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
    Danese S; Angelucci E
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase/Akt/mTOR and NF-κB signaling pathways.
    Park S; Regmi SC; Park SY; Lee EK; Chang JH; Ku SK; Kim DH; Kim JA
    Eur J Pharmacol; 2014 Jul; 735():184-92. PubMed ID: 24769511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review.
    El Mourabet M; El-Hachem S; Harrison JR; Binion DG
    Curr Drug Targets; 2010 Feb; 11(2):234-41. PubMed ID: 19916950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.